Search research articles
Contact Us
Filters
Showing results (11-20 of 202) with videos related to
Page
of 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1976
Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium
T Kishi, T Watanabe, K Folkers
Biochemical and Biophysical Research Communications
|
May 28, 1993
The activities of coenzyme Q10 and vitamin B6 for immune responses
K Folkers, M Morita, J McRee
Respiration; International Review of Thoracic Diseases
|
January 1, 1992
Exercise-limiting factors in respiratory distress
J Karlsson, B Diamant, K Folkers
Regulatory Peptides
|
December 1, 1982
Substance P enhances cation permeability of neuronal cell lines
G Reiser, K Folkers, B Hamprecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2024
HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics
Anthony S Fauci, Gregory K Folkers
Health Affairs (Project Hope)
|
November 6, 2009
Investing to meet the scientific challenges of HIV/AIDS
Anthony S Fauci, Gregory K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
November 1, 1975
Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs
H Kishi, T Kishi, K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1976
Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension
T Yamagami, N Shibata, K Folkers
Acta Physiologica Scandinavica
|
January 1, 1982
Characterization of two substance P antisera
E Brodin, G Nilsson, K Folkers
Biochemistry International
|
December 1, 1983
Structurally restricted conjugates of the beta-subunit of the human chorionic gonadotropin to produce antisera
K Folkers, S Shin, M Kappel
Page
of 21
Search research articles
Search
Showing results (11-20 of 202) with videos related to
Sort By:
Page
of 21
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1976
Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium
T Kishi, T Watanabe, K Folkers
Biochemical and Biophysical Research Communications
|
May 28, 1993
The activities of coenzyme Q10 and vitamin B6 for immune responses
K Folkers, M Morita, J McRee
Respiration; International Review of Thoracic Diseases
|
January 1, 1992
Exercise-limiting factors in respiratory distress
J Karlsson, B Diamant, K Folkers
Regulatory Peptides
|
December 1, 1982
Substance P enhances cation permeability of neuronal cell lines
G Reiser, K Folkers, B Hamprecht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2024
HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics
Anthony S Fauci, Gregory K Folkers
Health Affairs (Project Hope)
|
November 6, 2009
Investing to meet the scientific challenges of HIV/AIDS
Anthony S Fauci, Gregory K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
November 1, 1975
Bioenergetics in clinical medicine. III. Inhibition of coenzyme Q10-enzymes by clinically used anti-hypertensive drugs
H Kishi, T Kishi, K Folkers
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1976
Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension
T Yamagami, N Shibata, K Folkers
Acta Physiologica Scandinavica
|
January 1, 1982
Characterization of two substance P antisera
E Brodin, G Nilsson, K Folkers
Biochemistry International
|
December 1, 1983
Structurally restricted conjugates of the beta-subunit of the human chorionic gonadotropin to produce antisera
K Folkers, S Shin, M Kappel
Page
of 21